CD40 and neoplasm: Agonistic CD40 can drive the priming of a robust anti-tumor T cell response dependent on IFN-γ and Batf3 expression (8, 66, 67), while CD40 ligation on TAMs drives a tumoricidal response that depletes the stroma in the TME (143).